A carregar...
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
The cyclin-dependent kinase inhibitor 3 (CDKN3) gene, involved in mitosis, is upregulated in cervical cancer (CC). We investigated CDKN3 mRNA as a survival biomarker and potential therapeutic target for CC. CDKN3 mRNA was measured in 134 CC and 25 controls by quantitative PCR. A 5-year survival stud...
Na minha lista:
Publicado no: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570808/ https://ncbi.nlm.nih.gov/pubmed/26372210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0137397 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|